Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Clinical trial NCT05718375 · COMPLETED

Trial details

NCT number: NCT05718375
Sponsor: Curacle Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathies

Start date: 2023-02-14
Primary completion: 2025-11-12
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.